Dyno Therapeutics vs Chai Discovery

Uses AI to engineer AAV capsids as improved gene-delivery vectors, licensing designs to major pharma.

Builds foundation models for biomolecular structure prediction and fully de novo antibody design.

For subscribers

Including Funding rounds + valuations, Founders + executives, Products + tech stack, Headcount + HQ, Status timeline, and Roster connections.

Already subscribed? Sign in →